MCG Discovery Study in Emergency Departments (NCT06095557) | Clinical Trial Compass
CompletedNot Applicable
MCG Discovery Study in Emergency Departments
United States124 participantsStarted 2023-10-30
Plain-language summary
This prospective discovery study is designed to demonstrate the feasibility of using an unshielded, mobile MCG device in an Emergency Department (ED) setting. The main question it aims to answer is whether interpretable data can be reliably collected as part of an ED workflow.
Who can participate
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Presents to ED with symptoms of Acute Coronary Syndrome (ACS)
* Can provide written consent
Exclusion Criteria:
* Presents to ED with ST-Elevation Myocardial Infarction (STEMI)
* Presents to ED with Atrial Fibrillation
* Clear non-ischemic cause for symptoms (i.e. trauma)
* Active thoracic metal implants
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1This trial tested a device called MCG (Magnetocardiography) in emergency departments to detect heart problems like NSTEMI — how does this technology compare to the EKG or other heart tests I'm already getting, and could it offer any additional information in my case?
2Since this trial has already been completed and was measuring how often the MCG device produced usable data rather than whether it improved patient outcomes, what do we actually know so far about whether this technology is ready to help guide real treatment decisions?
3This study focused on acute coronary syndrome and NSTEMI specifically — given my diagnosis, is MCG testing something that might be available at this hospital or being used in any follow-up research that could be relevant to my care?
4Because this was essentially a feasibility or data-quality study rather than a trial testing a treatment, does the existence of this research change anything about the standard diagnostic approach you'd recommend for me right now?
5Are there other ongoing trials or newer studies building on this MCG research that my care team thinks might be worth exploring, given that this particular study has already wrapped up?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.